Nanoform Finland Plc – Manager’s Transactions – Albert Hæggström

Published: 2025-06-17 13:33:07 ET NANOFH.HE

Published on 06/17/2025 at 13:33

Nanoform Finland Plc | Company Release | June 17, 2025 at 20:32:00 EEST

Helsinki, Finland – Manager’s transaction related to Nanoform Finland Plc’s Member of the Board and CFO Albert Hæggström’s purchase of Nanoform Finland Plc shares:

Person subject to the notification requirementName: Albert HæggströmPosition: Member of the Board/Deputy memberIssuer: Nanoform Finland OyjLEI: 743700JJO2NU8LBS1592Notification type: INITIAL NOTIFICATIONReference number: 112447/4/4Transaction date: 2025-06-17 Outside a trading venueInstrument type: SHAREISIN: FI4000330972Nature of transaction: RECEIPT OF A SHARE-BASED INCENTIVETransaction details(1): Volume: 31504Unit price: 0 EURAggregated transactions(1): Volume: 31504Volume weighted average price: 0 EUR

For further information, please contact:Henri von HaartmanDirector of Investor [email protected]+46 7686 650 11

About NanoformNanoform is the medicine performance-enhancing company that leverages best-in-class innovative nanoparticle engineering technologies, expert formulation, and scalable GMP API manufacturing to enable superior medicines for patients. The company focuses on reducing clinical attrition and on enhancing drug molecules’ performance through its nanoforming technologies and formulation services, from pre-formulation to commercial scale. Nanoform will help improve bioavailability and drug delivery profiles, drive differentiation, patient adherence and extend the lifecycle potential of products. Nanoform’s shares are listed on the Premier-segment of Nasdaq First North Growth Market in Helsinki (ticker: NANOFH) and Stockholm (ticker: NANOFS). Certified Adviser: DNB Carnegie Investment Bank AB, +46 (0)73 856 42 65, [email protected]. For more information, please visit www.nanoform.com.

AttachmentsNanoform Finland Plc – Manager’s Transactions – Albert Hæggström